Filter Results :

Your search for Therapies returned 94 reports

Sort by


OncoVista Innovative Therapies, Inc. (OVIT) - Financial and Strategic SWOT Analysis Review

16 Jun 2015  |  Published by:  GlobalData
OncoVista Innovative Therapies, Inc. (OVIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng...

$ 125.00

Read More

Biotie Therapies Corp. (BTH1V) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company. It discovers and develops medicines for the treatment of neurodegenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease and other cognitive disorders; and inflammatory and fibrotic diseases. The company...

$ 300.00

Read More

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 300.00

Read More

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 May 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 250.00

Read More

Vital Therapies, Inc. (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 May 2015  |  Published by:  GlobalData
SummaryVital Therapies, Inc. (Vital Therapies) is a healthcare company. The company provides treatment of liver failure with the development of ELAD. Its ELAD product is a human-cell-based bioartificial liver. Vital Therapies’ ELAD is designed to stabilize liver function in patients with life-threat...

$ 250.00

Read More

Intra-Cellular Therapies, Inc. (ITCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

20 May 2015  |  Published by:  GlobalData
SummaryIntra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. It carries out the development of drugs for the treatment of diseases and disorders of the central nervous system (CNS). The company’s pipeline portfolio encompasses indications for the treatment of schizophrenia, bipolar di...

$ 250.00

Read More

Immunovative Therapies, Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

20 May 2015  |  Published by:  GlobalData
SummaryImmunovative Therapies, Ltd. (ITL) is a biopharmaceutical company that research and develops immunotherapy drug products for treatment of cancer and infectious disease. The company offers therapeutic vaccine products which include allovax, allostim, and cryostim. It develops products based on...

$ 250.00

Read More

Biotie Therapies Corp. (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

15 May 2015  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company. It discovers and develops medicines for the treatment of neurodegenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease and other cognitive disorders; and inflammatory and fibrotic diseases. The company...

$ 250.00

Read More

Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2015

22 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2015’, provides an overview of the Intra-Cellular Therapies, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic deve...

$ 1,500.00

Read More

Vital Therapies, Inc. (VTL) - Medical Equipment - Deals and Alliances Profile

21 Apr 2015  |  Published by:  GlobalData
SummaryVital Therapies, Inc. (Vital Therapies) is a healthcare company. The company provides treatment of liver failure with the development of ELAD. Its ELAD product is a human-cell-based bioartificial liver. Vital Therapies’ ELAD is designed to stabilize liver function in patients with life-threat...

$ 250.00

Read More

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

20 Apr 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 250.00

Read More

BioRestorative Therapies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

09 Apr 2015  |  Published by:  GlobalData
SummaryBioRestorative Therapies, Inc. (BRT) is a pharmaceutical research service provider. The company develops medical procedures by using cell and tissue protocols, and adult stem cells. It conducts stem cell programs, such as brtxDISC program, ThermoStem program, and brtx-C Cosmetic program. BRT’...

$ 250.00

Read More

Advanced Catheter Therapies, Inc. - Medical Equipment - Deals and Alliances Profile

07 Apr 2015  |  Published by:  GlobalData
SummaryAdvanced Catheter Therapies, Inc. (ACT) is an early stage medical device research and development company. The company provides new catheter technologies for vascular disease including inflammation, thrombosis, occlusions and restenosis. ACT is developing a device for restenosis (re-blockage ...

$ 250.00

Read More

The 2016 Report on Cancer Therapies: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

The 2016-2021 World Outlook for Cancer Therapies

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for cancer therapies across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is...

$ 995.00

Read More
Total 94 records.